section name header

Indications

REMS

Contraind./Precautions

Contraindicated in:

Use Cautiously in:

Adv. Reactions/Side Effects

CNS: SEIZURES, headache, dizziness.

EENT: visual abnormalities.

CV: hypotension, thromboembolism, thrombosis.

GI: diarrhea, nausea, vomiting.

MS: pain.

Misc: PO: ANAPHYLAXIS .

Interactions

Drug-Drug:

Availability

(Generic available)

Route/Dosage

see Calculator

Renal Impairment

Renal Impairment

US Brand Names

Cyklokapron, Lysteda

Action

Therapeutic Effects:

Classifications

Therapeutic Classification: hemostatic agents

Pharmacologic Classification: antifibrinolytics, plasminogen inactivators

Pharmacokinetics

Absorption: 100% bioavailable with IV administration; 45% bioavailability after oral administration.

Distribution: Penetrates readily into joint fluid and synovial membranes.

Metabolism/Excretion: 95% excreted unchanged in urine.

Half-life: 2 hr (IV) ( in renal impairment); 11 hr (PO).

Time/Action Profile

(blood levels)

ROUTEONSETPEAKDURATION
IVunknownunknown7–8 hr
POunknown2.5 hrunknown

Patient/Family Teaching

Pronunciation

tran-ex-AM-ikAS -id audio

Code

NDC Code*